FERHANOĞLU, A. B. Et Al. 2017. Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey. Hematological Oncology , vol.35 , 321-323.

FERHANOĞLU, A. B., BEKÖZ, H. S., KARADURMUŞ, N., PAYDAŞ, S., GÜLBAŞ, z., TÜRKER, F. A., ... TOPTAŞ, T.(2017). Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey. Hematological Oncology , vol.35, 321-323.

FERHANOĞLU, AHMET Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey," Hematological Oncology , vol.35, 321-323, 2017

FERHANOĞLU, AHMET B. Et Al. "Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey." Hematological Oncology , vol.35, pp.321-323, 2017

FERHANOĞLU, A. B. Et Al. (2017) . "Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey." Hematological Oncology , vol.35, pp.321-323.

@article{article, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Nivolumab for relapsed or refractory Hodgkin lymphoma: Experience in Turkey}, journal={Hematological Oncology}, year=2017, pages={321-323} }